ABSTRACT. Cummings TM, White AR. Needling therapies in the management of myofascial trigger point pain: a systematic review. Arch Phys Med Rehabil 2001;82:986-92.
Myofascial trigger point pain is commonly diagnosed. Trigger points were the primary source of pain in 74% of 96 patients with musculoskeletal pain seen by a neurologist in a community pain medical center, 2 and in 85% of 283 patients consecutively admitted to a comprehensive pain center. 3 Fiftyfive percent of 164 patients referred to a dental clinic for chronic head and neck pain were found to have active myofascial trigger points as the cause of their pain, 4 as were 30% of those from a consecutive series of 172 patients presenting with pain to a university primary care internal medicine group practice. 5 A study of musculoskeletal disorders in villagers from rural Thailand found that myofascial pain was the primary diagnosis in 36% of 431 subjects with pain during the previous 7 days. 6 These epidemiologic studies suggest that myofascial trigger point pain is an important source of morbidity in the community. However, trigger points are still the focus of some controversy. [7] [8] [9] Attempts to establish agreement between examiners on the presence or absence of trigger points in patients in a reliable and reproducible manner have proved difficult, 10-13 but, with uniform examination techniques established by a short period of training, experienced clinicians have shown interrater reliability. 13 Further work is underway in this area. 14 Myofascial trigger points causing pain and dysfunction are commonly treated by injection or dry needling, 15 which are considered by many to be equally effective. In 1979, Lewit 16 emphasized the needle effect as distinct from that of the injected substance. A variety of noninvasive methods are also used, ranging from physical therapies, such as heat and massage, to mud baths 17 or magnetic fields. 18 Hey and Helewa 19 concluded, from a review of the literature on myofascial pain syndrome, that no reported treatment, including trigger point injections, had been more efficacious than control interventions. In a review of injection therapy for trigger and tender points, Borg-Stein and Stein 20 concluded that trigger point injections seem to be effective as a general approach, but none of the 5 randomized controlled trials included in the review provided evidence for the efficacy of injection therapy beyond placebo in myofascial trigger point pain. To establish whether needling therapies have specific efficacy in the management of myofascial pain (ie, efficacy beyond placebo) and to update the literature to include recent papers, we undertook a systematic review.
METHODS

Data Sources
Computerized literature searches were performed for controlled trials and reviews of needling therapies for myofascial trigger point pain, using the following databases: PubMed (from 1966), Ovid MEDLINE (from 1966), Ovid EMBASE (from 1988), the Cochrane Library (from inception), AMED (from inception), and CISCOM (from inception), all to July 1999. Search terms used were myofascial pain or trigger point, and acup*, needl*, inject*, block*, *caine, or tox*. We also included the clinical diagnosis of whiplash in the word search because we believed that some authors may use this term to define a population of patients suffering predominantly from myofascial pain without mentioning trigger points or myofascial pain in the paper. When database facilities permitted, searches were limited to controlled trials and reviews.
Study Selection
Papers were included if they described randomized controlled trials in which some form of needling therapy was used to treat clinical pain or dysfunction of the human musculoskeletal system. Pain or dysfunction had to be described as myofascial or arising from muscular trigger points, or to be, in our opinion, likely to have resulted predominantly from myofascial trigger points (eg, typical whiplash syndrome but not chronic back pain). Comparative trials were included if at least 1 group had a form of needling therapy. The reference lists of all papers identified were searched for further articles, as were the references from relevant musculoskeletal medicine textbooks.
Data Extraction
Data were extracted independently by both authors using a specially designed form. Differences were resolved by discussion. For each study the following details were extracted: inclusion and exclusion criteria, design, randomization, description of dropouts and blinding, outcome measures, details of the interventions used, and results.
Quality assessment. A methods quality score, that was graded using the principles of Jadad, 21 considered randomization, blinding, and description of dropouts. A study that was described as randomized was awarded 1 point; if the method of randomization was described and appropriate, a second point was awarded; if the method was inappropriate (eg, alternation), 1 point was deducted. We awarded 2 points for blinding if the assessor was blind and subjects were blind, using an appropriate method. Another point was awarded if dropouts and withdrawals were described. Trials that gained 3 or more points, from the maximum score of 5, were considered of higher quality.
Data Synthesis
Exclusions. The searches revealed 61 potentially relevant papers, 38 of which were subsequently excluded (table 1) .
Description of included trials. The 23 trials that met the inclusion criteria of the review described 38 comparisons between different interventions that were relevant to the review. It became clear that the trials could be divided into 4 categories: (1) direct wet needling, in which an injection is aimed directly at the trigger point; (2) direct dry needling, in which a hypodermic needle (a hollow, bevelled needled used for injection) or a solid needle (an acupuncture needle) is aimed directly at the trigger point; (3) indirect dry needling, in which the needle was placed superficially or deep into classical acupuncture points but no clear attempt was made to needle a trigger point directly; and (4) indirect wet needling, in which an injection was placed in the skin or subcutaneous tissue over a trigger point. Direct wet needling was investigated in 14 trials, direct dry needling in 5, and there were 3 trials in each of the 2 indirect categories. Two trials were included in both direct-dry and direct-wet categories because they contained comparisons relevant to the assessment of the efficacy of each.
The clinical conditions addressed were chronic in 10 of the trials, [60] [61] [62] [63] [64] [65] [66] [67] [68] [69] mixed duration in 7, [70] [71] [72] [73] [74] [75] [76] and acute in 3. [77] [78] [79] In the remaining 3, the duration of the condition was not specified. [80] [81] [82] Many different parts of the body were represented, and the trials were performed in 6 different countries. Twenty trials were parallel arm, and 3 used a crossover design.
Quality of included trials. Four papers gained the maximum score of 5 points, 72,76-78 3 scored 4 points, 65,66,68 6 scored 3 points, 61, 69, 71, 75, 79, 82 and the remaining 10 scored 2 points or less. One paper, 63 described as double blind, was not considered blinded for the outcome relevant to this review; it was given 1 point. Table 2 summarizes the details of the 14 trials that investigated direct wet needling. Wet needling with different substances was compared in 10 studies, 8 of which found that the Macdonald et al 22 Not predominantly myofascial pain Petri et al 23 Not predominantly myofascial pain Petri and Langley 24 Not predominantly myofascial pain Berry et al 25 Not predominantly myofascial pain Crockett et al 26 No needling intervention included Dacre et al 27 Not predominantly myofascial pain Dorigo et al 28 Not RCT Fischer 29 Not RCT Fox et al 30 Not predominantly myofascial pain Freund and Schwartz 31 Not RCT Frost et al 32 Same as trial in Frost et al 77 Gallacchi et al 33 Not predominantly myofascial pain Gnatz 34 Not RCT Gunn et al 35 Not predominantly myofascial pain Hay 36 Not RCT Hendler et al 37 Not RCT Heuser 38 Not randomized Hollingworth et al 39 Not predominantly myofascial pain Hong and Hsueh 40 Same intervention in each group Jacob 41 Not RCT Jaeger and
Outcomes
Skootsky 42 Abstract only, no data or statistics Kopp and Wenneberg 43 Not predominantly myofascial pain Kopp et al 44 Not predominantly myofascial pain Kovacs et al 45 Not predominantly myofascial pain Li et al 46 Not predominantly myofascial pain Loy 47 Not predominantly myofascial pain Mameli et al 48 Not available from British Library McMillan and Blasberg 49 Not randomized Mencke et al 50 Not available from British Library Padamsee et al 51 Not predominantly myofascial pain Petrie and
Hazleman 52 Not predominantly myofascial pain Phero et al 53 Not RCT Pullen 54 Not RCT Raustia 55 Not predominantly myofascial pain Salim 56 Not randomized Tsumura and Hoshiga 57 Not RCT Vecchio et al 58 Not predominantly myofascial pain Withrington et al 59 Not predominantly myofascial pain Abbreviation: RCT, randomized control trial. effect was independent of the injected substance. All 7 of the higher quality trials came to the same conclusion. Table 3 summarizes the details of the 5 trials that investigated direct dry needling. Three of those compared dry to wet needling, and they all found no difference between the groups. One was a double-dummy study that found that dry needling had a similar effect to a therapy that is of known efficacy in migraine prophylaxis, oral metoprolol. The other compared dry needling at correct and incorrect sites but was not correctly randomized and suffered major loss to follow-up. Table 4 summarizes the details of the 3 trials that compared indirect dry needling with various interventions. Needling alone did not appear to be superior, although these trials were of poor quality. Table 5 summarizes the details of the 3 trials that investigated indirect wet needling. Overall, these suggest that sub-or intracutaneous injection of water or saline over trigger points is ineffective. Two trials attempted to test the specific efficacy (ie, efficacy beyond placebo) of needling in the treatment of myofascial trigger point pain. 70, 75 The dropout rate was 48% in the trial by Chu, 70 and the study was neither blinded nor correctly randomized. McMillan et al 75 used potentially active interventions in the control group, stimulating the same cutaneous receptive field as the test intervention. Thus, from a neurophysiologic view, all 3 groups in the McMillan trial were needled or injected in a similar place, and all improved significantly.
DISCUSSION
Findings
The principal findings of the present review are that, when treating myofascial trigger point pain with trigger point injection, the nature of the injected substance makes no difference to the outcome, and that wet needling is not therapeutically superior to dry needling. These conclusions are supported by all the high-quality trials in the review. The original trials were performed over an 18-year period, in many independent centers, and cover various manifestations of myofascial trigger point pain. The review did not find any rigorous evidence that needling therapies have an effect beyond placebo in myofascial trigger point pain.
Limitations
Inclusion and exclusion of certain trials resulted from the judgment of the authors regarding the predominance of myofascial trigger point pain in the study population. We included 4 trials 61, 65, 79, 82 that did not specify that the study population suffered predominantly from myofascial trigger point pain. Exclusion of these trials would not alter the overall conclusions.
Simons et al 1 recommend that the minimum acceptable criteria for diagnosing a myofascial trigger point are the combination of spot tenderness in a palpable band of skeletal muscle and subject recognition of the pain, although palpation of a taut band depends on the accessibility of the muscle. A potential limitation of the present review is that only 8 of the 23 trials included described these or similar minimum criteria. 60, 62, 63, 66, 68, 71, 72, 81 Furthermore, it was suggested in 1 of the included papers that trigger point needling is more likely to be effective if it produces a local twitch response. 66 Local twitch responses were not reported in any other study.
Simons 1 commented that saline for injection commonly includes 0.9% benzyl alcohol as a bacteriostatic agent, which has some local anesthetic properties. Only 2 of the included tri- als 64, 68 reported the use of saline without preservative. This could clearly be a limitation if injection of saline was otherwise an inactive control. It has already been noted that dry needling alone has a similar effect to local anesthetic injection, so whether the preservative in saline has a significant local anesthetic effect or not, the conclusions of this review are not affected.
Other Reviews
The main conclusion of this review is consistent with that of Hey and Helewa. 19 However, the present review was performed systematically and included quality assessment.
Borg-Stein and Stein 20 state that trigger point injections "appear to be effective," as 1 of 8 conclusions. However, this statement is not supported by rigorous evidence from cited trials, and their review is narrative rather than systematic. We confirmed in the present review that all groups investigated, in whom trigger points were directly needled, showed marked improvement in their symptoms (the findings are less clear for indirect treatments). It appears, therefore, that direct trigger point needling is effective. However, the important question about health interventions is whether they can be shown to be superior to placebo.
Implications for Treatment and Further Research
Although the present review does not provide proof of efficacy for any individual technique, it clearly shows that no difference exists between trigger point injections with different substances, or between dry and wet needling. Because no technique is better than any other, we recommend that the method safest and most comfortable for the patient should be used.
The most urgent requirement for further research is to establish the efficacy beyond placebo of trigger point needling in the treatment of myofascial trigger point pain. This research will require the use of a credible yet inactive placebo for the needle. For years, clinical acupuncture research has struggled with the concept of an adequate control for the needle. 15 Promising solutions are now emerging, such as a blunted needle with telescopic handle. 83, 84 This device appears to pierce the skin and has been shown to be a valid placebo. 83 Such developments should be applied to test the efficacy of trigger point needling beyond placebo. 
CONCLUSION
The hypothesis that needling therapies have specific efficacy (ie, efficacy beyond placebo) in the treatment of myofascial trigger point pain is neither supported nor refuted by the research to date. However, the present review suggests that any effect these therapies may have is likely due to the needle or placebo, rather than to the injection, whether it be of liquid in general or a particular substance. Because marked improvements occurred in all groups in which trigger points were directly needled, further research is required to investigate whether trigger point needling has an effect beyond placebo, with emphasis on the use of an adequate control for the needle.
